Healthcare - Biotechnology - NASDAQ - US
$ 9.47
-6.24 %
$ 563 M
Market Cap
-2.62
P/E
Price Target
Average
95.35%
Revenue Forecast
Estimate
99.68%
EBIT
Estimate
19.30%
Net Income
Estimate
21.82%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
IGM Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for IGMS of $18.5 , with forecasts ranging from a low of $12 to a high of $25 .
IGMS Lowest Price Target
Wall Street Target
12 USD
26.72%
IGMS Average Price Target
Wall Street Target
18.5 USD
95.35%
IGMS Highest Price Target
Wall Street Target
25 USD
163.99%
REVENUE FORECAST
Revenue Forecast Chart IGMS
EBIT FORECAST
EBIT Forecast Chart IGMS
NET INCOME FORECAST
Net Income Chart IGMS